Molecular genetic analysis of familial hypercholesterolemia: Spectrum and regional difference of LDL receptor gene mutations in Japanese population

Atherosclerosis

Volumn 165, Issue 2, 2002, Pages 335-342

  Yu, Wenxin ^a   Nohara, Atsushi ^a   Higashikata, Toshinori ^a   Lu, Hong ^a   Inazu, Akihiro ^a   Mabuchi, Hiroshi ^a  

^a Graduate School of Natural Science and Technology   (Japan)

Author keywords

Apolipoprotein E; Familial hypercholesterolemia; Low density lipoprotein receptor; Mutation; Scavenger receptor class B type I

Indexed keywords

APOLIPOPROTEIN B; DNA; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; RECEPTOR SUBTYPE; SCAVENGER RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SEQUENCE; FAMILIAL DISEASE; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC POLYMORPHISM; HETEROZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; JAPAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; SOUTHERN BLOTTING; BLOOD; GENETICS; HETEROZYGOTE; HYPERLIPOPROTEINEMIA TYPE 2; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE;

ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; JAPAN; LIPIDS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, LDL;

EID: 0036889631     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00249-6     Document Type: Article

References (35)

1. Goldstein J.L., Hobbs H.H., Brown M.S. Familial hypercholesterolemia. Scriver C.R., Beaudet A.L., Sly W.S., Valle I., The metabolic basis of inherited disease. 8th ed. 2001;2863-2913 McGraw-Hill, New York.
2. Innerarity T.L., Weisgraber K.H., Arnold K.S., Mahley R.W., Krauss R.M., Vega G.L., et al. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc. Natl. Acad. Sci. USA. 84:1987;6919-6923.
3. Hobbs H.H., Brown M.S., Goldstein J.L. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutat. 1:1992;445-466.
4. Varret M., Rabes J.P., Thiart R., Kotze M.J., Baron H., Cenarro A., et al. Ldlr database-new additions to the database and the software, and results of the first molecular analysis. Nucleic Acids Res. 26:1998;248-252.
5. Pullinger C.R., Hennessy L.K., Chatterton J.E., Liu W., Love J.A., Mendel C.M., et al. Familial ligand-defective apolipoprotein B: identification of a new mutation that decreases LDL-receptor binding activity. J. Clin. Invest. 95:1995;1225-1234.
6. Umans-Eckenhausen M.A.W., Defesche J.C., Sijbrands E.J.G., Scheerder R.L.J.M., Kastelein J.J.P. Review of first 5 years of screening for familial hyper-cholesterolemia in the Netherlands. Lancet. 357:2001;165-168.
7. Garcia C.K., Wilund K., Arca M., Zuliani G., Fellin R., Maioli M., et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science. 292:2001;1394-1398.
8. Kajinami K., Mabuchi H., Itoh H., Michishita I., Takeda M., Wakasugi T., et al. New variant of low density lipoprotein receptor gene: FH-Tonami. Arteriosclerosis. 8:1988;187-192.
9. Yamakawa K., Takada K., Yanagi H., Tsuchiya S., Kawai K., Nakagawa S., et al. Three novel partial deletions of the low-density lipoprotein (LDL) receptor gene in familial hypercholesterolemia. Hum. Genet. 82:1989;317-321.
10. Kajinami K., Mabuchi H., Inazu A., Fujita H., Koizumi J., Takeda R., et al. Novel gene mutations at low density lipoprotein receptor locus: FH-Kanazawa and FH-Okayama. J. Intern. Med. 227:1990;247-251.
11. Yamakawa-Kobayashi K., Kobayashi T., Saku K., Arakawa K., Hamaguchi H. Two novel frameshift mutations associated with the presence of direct repeats of the LDL receptor gene in familial hypercholesterolemia. Hum. Genet. 92:1993;331-335.
12. Yamakawa-Kobayashi K., Kobayashi T., Yanagi H., Shimakura Y., Satoh J., Hamaguchi H. A novel complex mutation in the LDL receptor gene probably caused by the simultaneous occurrence of deletion and insertion in the same region. Hum. Genet. 93:1994;625-628.
13. Maruyama T., Miyake Y., Tajima S., Harada-Shiba M., Yamamura T., Tsushima M., et al. Common mutations in the low-density-lipoprotein-receptor gene causing familial hypercholesterolemia in the Japanese population. Arterioscler. Thromb. Vasc. Biol. 15:1995;1713-1718.
14. Hirayama T., Yamaki E., Hata A., Tsuji M., Hashimoto K., Yamamoto M., et al. Five familial hypercholesterolemic kindreds in Japan with novel mutations of the LDL receptor gene. J. Hum. Genet. 43:1998;250-254.
15. Tashiro J., Endo M., Bujo H., Shinomiya M., Morisaki N., Saito Y. New type of the internalization-defective low-density lipoprotein receptor owing to two-nucleotide deletion (2199delCA or 2201delCA) in Japanese patients with familial hyper-cholesterolemia. Eur. J. Clin. Invest. 28:1998;712-719.
16. Hattori H., Nagano M., Iwata F., Homma Y., Egarashi T., Okada T. Identification of recurrent and novel mutations in the LDL receptor gene in Japanese familial hypercholesterolemia. Hum. Mutat. 14:1999;87. On line.
17. Mabuchi H., Koizumi J., Shimizu M., Takeda R. The Hokuriku FH-CAD study group. Development of coronary heart disease in familial hypercholesterolemia. Circulation. 79:1989;225-232.
18. Friedewald W.I., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
19. Nissen H., Gulgberg P., Hansen A.B., Petersen E., Horder M. Clinically applicable mutation screening in familial hypercholesterolemia. Hum. Mutat. 8:1996;168-177.
20. Hixon J.E., Vernier D.I. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31:1990;545-548.
21. Acton S., Osgood D., Donoghue M., Corella D., Pocovi M., Cenarro A., et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler. Thromb. Vasc. Biol. 19:1999;1734-1743.
22. Yamamoto T., Davis C.G., Brown M.S., Schneider W.J., Casey M.L., Goldstein J.L., et al. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell. 39:1984;27-38.
23. Kim S.H., Bae J.H., Chae J.J., Kim U.K., Choe S.J., Yong N.K., et al. Long-distance PCR-based screening for large rearrangements of the LDL receptor gene in Korean patients with familial hypercholesterolemia. Clin. Chem. 45:1999;1424-1430.
24. Nohara A., Yagi K., Inazu A., Kajinami K., Koizumi J., Mabuchi H. Absence of familial defective apolipoprotein B-100 in Japanese patients with familial hypercholesterolemia. Lancet. 345:1995;1438.
25. Bertolini S., Cantafora A., Averna M., Cortese C., Motti C., Martini S., et al. Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype. Arterioscler. Thromb. Vasc. Biol. 20:2000;E41-52.
26. Durst R., Colombo R., Shpitzen S., Avi L.B., Friedlander Y., Wexler R., et al. Recent origin and spread of a common Lithuanian mutation, G197delLDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews. Am. J. Hum. Genet. 68:2001;1172-1188.
27. Tikkanen M.J., Huttunen J.K., Ehnholm C., Pietinen P. Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis. 10:1990;284-288.
28. Xu C.F., Boerwinkle E., Tikkanen M.J., Huttunen J.K., Humphries S.E., Talmud P.J. Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genet. Epidemiol. 7:1990;261-275.
29. Mabuchi H., Haba T., Ueda K., Ueda R., Tatami R., Ito S., et al. Serum lipids and coronary heart disease in heterozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis. 28:1977;417-423.
30. Webb J.C., Patel D.D., Shoulders C.C., Knight B.L., Soutar A.K. Genetic variation at a splicing branch piont in intron 9 of the low density lipoprotein (LDL)-receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolemia and a common polymorphism. Hum. Mol. Genet. 5:1996;1325-1331.
31. Bindler R., Hwang S.P.L., Ratnasabapapathy R., Williams D.L. Degradation of apolipoprotein II mRNA occurs via endonucleolytic cleavage at 5′-AAU-3′/5′-UAA-3′ elements in single-stranded loop domains of the 3′-non-coding region. J. Biol. Chem. 264:1989;16910-16918.
32. Lee M.H., Lu K., Patel S.B. Genetic basis of sitosterolemia. Curr. Opin. Lipidol. 12:2001;141-149.
33. Khoo K.L., van Acker P., Defesche J.C., Tan H., van de Kerkhof L., Heijnen-van Eijk S.J., et al. Low-density-lipoprotein receptor gene mutations in a southeast Asian population with familial hypercholesterolemia. Clin. Genet. 58:2000;98-105.
34. Sun X.M., Patel D.D., Webb J.C., Knight B.L., Fan L.M., Cai H.J., et al. Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype. Arterioscler. Thromb. 14:1994;85-94.
35. Varret M., Rabès J.P., Saint-jore B., Cenarro A., Marinoni J.C., Civeira F., et al. A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32. Am. J. Hum. Genet. 64:1999;1378-1387.